Le Lézard
Classified in: Health
Subjects: NPT, SVY

Pancreatic Cancer Action Network Mourns Loss Of Aretha Franklin


MANHATTAN BEACH, Calif., Aug. 16, 2018 /PRNewswire/ -- The family of Aretha Franklin confirmed Thursday that the 18-time Grammy Award-winning singer and songwriter best known for hits like "Respect," "(You Make Me Feel Like) A Natural Woman" and "Spanish Harlem," died of pancreatic cancer. She was 76 years old.

The family of Aretha Franklin confirmed on Thursday that the 18-time Grammy Award-winning singer and songwriter passed away from pancreatic cancer.

Pancreatic cancer has the lowest five-year survival rate of any major cancer in the United States at only 9 percent. In 2018, more than 55,000 people will be diagnosed and approximately 44,000 will die from the disease.

Franklin died from a form of pancreatic cancer known as pancreatic neuroendocrine cancer (pancreatic NETs or PNETs), which account for about six percent of all pancreatic tumors. They develop from the abnormal growth of endocrine (hormone-producing) cells in the pancreas called islet cells. This is why these tumors are sometimes referred to as "islet cell tumors."

Also important to note, African-Americans have the highest incidence rate of pancreatic cancer, between 28 percent and 59 percent higher than the incidence rates for other racial/ethnic groups.

"We mourn the loss of a legend and urge the public to take action against pancreatic cancer," said Julie Fleshman, JD, MBA, president and CEO of the Pancreatic Cancer Action Network (PanCAN). "We are working diligently to change outcomes for patients but we need more people to get involved and help fund critical research."

Franklin joins a growing list of other notable public figures, actors and musicians who've passed away from pancreatic cancer. Just this year, the disease has claimed the lives of Joe Jackson, the patriarch of the Jackson music dynasty, as well as "Diff'rent Strokes" and "The Facts of Life" actress Charlotte Rae.

PanCAN has an urgent goal to improve outcomes for patients battling the disease today and double survival by 2020. The organization attacks pancreatic cancer using a comprehensive approach focused on research, clinical initiatives, patient services and advocacy.

Support the Pancreatic Cancer Action Network's urgent goal to double survival by 2020. Follow the Pancreatic Cancer Action Network on Twitter, Instagram and Facebook.

About the Pancreatic Cancer Action Network
The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world's toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to double survival by 2020.

Media Contact:
Terra Hall
Media Relations Manager
Pancreatic Cancer Action Network
Direct: 310-706-3311
Cell: 212-380-3919 
Email: [email protected]

The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world's toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve outcomes today and to double survival by 2020. (PRNewsfoto/Pancreatic Cancer Action Network)

SOURCE Pancreatic Cancer Action Network


These press releases may also interest you

at 04:31
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

at 03:16
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...



News published on and distributed by: